Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15332205 | 0.82 | PIK3CD (0.41) | — | |
| SCHEMBL15541386 | 0.80 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL3614160 | 0.76 | KDM4E (0.33) | — | |
| SCHEMBL15696992 | 0.75 | PIK3CD (0.34) | MEN1KMT2A | |
| SCHEMBL2230690 | 0.74 | MAPT (0.32) | — | |
| SCHEMBL343340 | 0.72 | CA12 (0.34) | MEN1KMT2A | |
| SCHEMBL15387106 | 0.71 | PIK3CD (0.32) | MEN1KMT2A | |
| SCHEMBL341251 | 0.70 | PAX8 (0.35) | — | |
| SCHEMBL18776435 | 0.69 | PIK3CD (0.33) | MEN1KMT2A | |
| SCHEMBL26292503 | 0.69 | MEN1 (0.40) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2651876-B1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECH AG (CH) | 2017-08-09 | — | — | EP | claimed |
| US-8877955-B2 | Secondary aminosilanes | SIKA TECHNOLOGY AG (CH) | 2014-11-04 | — | — | US | claimed |
| US-8703844-B2 | Low-viscosity epoxy resin composition with low blushing | SIKA TECHNOLOGY AG (CH) | 2014-04-22 | — | — | US | claimed |
| US-20130281562-A1 | SECONDARY AMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2013-10-24 | — | — | US | claimed |
| EP-2651956-A1 | SECONDARY AMINOSILANES | Sika Technology AG (CH) | 2013-10-23 | — | — | EP | claimed |
| EP-2651876-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | Sika Technology AG (CH) | 2013-10-23 | — | — | EP | claimed |
| US-20130261270-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-10-03 | — | — | US | claimed |
| US-20120270967-A1 | LOW-VISCOSITY EPOXY RESIN COMPOSITION WITH LOW BLUSHING | SIKA TECHNOLOGY AG (CH) | 2012-10-25 | — | — | US | claimed |
| WO-2012080266-A1 | SECONDARY AMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | claimed |
| WO-2012080265-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | claimed |
| EP-2336213-A1 | Low viscosity epoxide resin compound with low blushing | Sika Technology AG (CH) | 2011-06-22 | — | — | EP | claimed |
| WO-2011069846-A1 | LOW-VISCOSITY EPOXY RESIN COMPOSITION WITH LOW BLUSHING | SIKA TECHNOLOGY AG (CH) | 2011-06-16 | — | — | WO | claimed |
| US-12209157-B2 | Polyurethane composition having a low content of monomeric diisocyantes | SIKA TECHNOLOGY AG (CH) | 2025-01-28 | — | — | US | disclosed |
| US-20230312875-A1 | CYCLOALIPHATIC ALDIMINE MIXTURE | SIKA TECHNOLOGY AG (CH) | 2023-10-05 | — | — | US | disclosed |
| EP-4229031-A1 | MOISTURE-CURING POLYURETHANE COMPOSITION | Sika Technology AG (CH) | 2023-08-23 | — | — | EP | disclosed |
| EP-4229032-A1 | CYCLOALIPHATIC ALDIMINE MIXTURE | Sika Technology AG (CH) | 2023-08-23 | — | — | EP | disclosed |
| WO-2012080266-A1 | SECONDARY AMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012080265-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | disclosed |
| EP-2465843-A1 | Polyamines with secondary aliphatic amines | Sika Technology AG (CH) | 2012-06-20 | — | — | EP | disclosed |
| EP-2336213-A1 | Low viscosity epoxide resin compound with low blushing | Sika Technology AG (CH) | 2011-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281562-A1 | SECONDARY AMINOSILANES | AS3MT, SRM, MSN | MEN1 2889/4885KMT2A 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.